Joy for All vs Moflin vs Paro: dementia companions compared
Buy the $159.99 Joy for All cat. It is the only one of the three that a family can order today and that has a randomized care-home trial behind it, where neuropsychiatric symptoms fell in the robot homes and rose in the controls.
Three very different machines get handed to people living with dementia, and they get discussed as if a robot for a dementia patient were one product with three brands on it. A Joy for All cat is $159.99 and runs on C batteries. Moflin is $429 and needs its charging bed every five hours. PARO publishes no price at all and arrives through a distributor, with clinician training courses attached.
For a family buying for one person, the Joy for All is the defensible choice, and cost is the smaller half of the reason.
The three, side by side
| Joy for All cat or pup | Moflin | PARO | |
|---|---|---|---|
| What it is | Battery-powered robotic cat or dog | AI fur companion, no face, no limbs | Therapeutic baby harp seal |
| Price | $159.99 cat, $179.99 pup (joyforall.com, 2026-08-09) | $429.00 (Amazon, sold by Casio America, 2026-08-09) | No published price; distributor quote |
| Power | 4 C batteries, included | 1,200 mAh Li-ion, about 5 hours per charge | Not published |
| Setup | Nothing. Switch and go | Optional MofLife app; charging bed | Supplied through PARO Robots U.S. |
| Dementia evidence | Cluster RCT in 8 care homes, plus a 2026 home pilot | One qualitative study, 3 nursing homes | 12 studies, 1,461 participants, pooled |
| Realistic buyer | Families and care homes | Families who want the newer thing | Facilities with a budget line |
PARO has the deepest file and no price tag
PARO is the clinical benchmark the rest of this literature measures itself against. It is the eighth generation of a design in use in Japan and Europe since 2003, developed at Japan's AIST, with five sensor types (tactile, light, audio, temperature, posture), and it holds a Guinness World Record as the most therapeutic robot (parorobots.com). It learns a name and adjusts behavior toward whatever gets it stroked.
The evidence is the best in this category and still modest. A 2023 systematic review and meta-analysis in International Journal of Nursing Studies pooled 12 articles and 1,461 participants with dementia: a moderate effect on medication use (SMD -0.63), smaller effects on depression (-0.40), agitation (-0.27) and anxiety (-0.17), a negligible effect on sleep time. The authors graded the evidence quality for every one of those outcomes as low.
A July 2026 meta-analysis in International Journal of Medical Informatics narrowed to six randomized trials in Australian healthcare settings, 1,444 participants, and found agitation down (SMD -0.44, 95% CI -0.70 to -0.18, p = 0.0008) and anxiety down (-0.59, 95% CI -0.91 to -0.27, p = 0.0003). Depression did not clear significance. One note for anyone checking the arithmetic: the abstract gives depression as SMD -0.44, 95% CI -0.95 to -0.07, p = 0.09, an interval and a p value that disagree, so take that outcome as the authors do, unclear.
On the regulatory line everyone repeats: FDA's device registration database lists PARO ROBOTS U.S. INC. of Itasca, Illinois (registration 3009118691), with a device listing created 2012-06-27 under product code HCC, "Device, Biofeedback," 21 CFR 882.5050, device class 2. The listing carries no 510(k) number, and a search of FDA's 510(k) clearance database returns no PARO record (openFDA, data last updated 2026-07-27). "Registered as a Class II biofeedback device" is supportable. "FDA-cleared in 2009," the line most articles use, I cannot match to a clearance record.
The price I cannot give you. PARO sells by distributor contact rather than a store page, secondary sources have repeated $5,000 to $6,000 for years, and I have no quote confirming it. Treat it as a facility purchase.
Joy for All is the only one with both a trial and a checkout button
Ageless Innovation's pets are the cheap, unglamorous option that keeps showing up in the research. On joyforall.com: cats $159.99, with Tuxedo out of stock and pointed to Amazon, and the Golden Pup $179.99, out of stock on the maker's own site and also pointed to Amazon. Four C batteries, included. No app, no Wi-Fi, no account, nothing to cancel. The pup weighs 3.9 pounds, real lap weight for a frail person, so consider the cat first. If you have never had one in your hands, someone who works in this field has.
The trial worth knowing about is a stratified cluster randomized controlled trial published in JMIR Aging in 2022 (NCT04168463). Eight care homes in Cornwall, UK: four received two Joy for All devices each, one cat and one dog, for four months; four continued as usual. Neuropsychiatric Inventory scores decreased in the robot homes and increased in the controls (P < .001), and staff-reported occupational disruptiveness improved (P = .03). Two findings there matter more than the p values. Residents who engaged had more severe dementia, not less. And the researchers found no novelty effect across sustained use, which is the failure families most often expect.
A March 2026 pilot RCT in American Journal of Geriatric Psychiatry adds a home-setting result: 50 caregiver and older-adult pairs from Pennsylvania's Caregiver Support Program, half of the older adults with a dementia diagnosis, positive affect up 7.28 points (95% CI 3.1 to 11.4, p = 0.001). Where robot pets miss, including depression, is laid out in the therapy evidence review.
Moflin's file is one study long
Casio's Moflin is the most charming object of the three and the least studied. Specs from casio.com/us/moflin: about 260 g, 130 x 90 x 180 mm, a 1,200 mAh lithium-ion cell good for roughly five hours of typical use at 25 C and three and a half hours to recharge, microphone, illuminance, touch and motion sensors, one-year warranty. Price $429.00 on the Amazon listing sold by Casio America, with no subscription attached, which counts for something next to the app-tethered tier.
The dementia-relevant research is one paper: a qualitative exploratory study published 2026-07-17 in Zeitschrift für Gerontologie und Geriatrie, run in three Swiss nursing homes with guided interviews and structured observation. Staff used Moflin to calm residents, stimulate them and prompt conversation, and said its simplicity supported long-term use. No control group, no outcome measures, no effect sizes. Promising first look, not evidence of benefit, and Casio does not market it as a dementia product. Our read of the hardware is in the Moflin review.
What actually decides it in the room
Power is the underrated one. C cells last months and can be changed by anyone. Moflin's five-hour battery means someone has to notice it is flat and put it back in its bed, every day, forever, which in memory care is a staff task added to a staff shortage.
Cleaning is the second. Casio's guidance is to brush the fur gently and wipe it with a damp cloth. Joy for All builds for spills and shared handling. In a household where the pet gets fed at the table, that difference decides how long it survives.
Supervision is the third, and the newest data point. A February 2026 cluster-randomized trial in Alzheimer's & Dementia assigned six group homes to self-directed PARO sessions once or three times a week for a month, 85 participants, no clinician running the session. Caregiver burden dropped in the thrice-weekly group (least-squares mean -3.29, 95% CI -6.26 to -0.32, p = 0.030). Symptom severity improved but missed significance (-1.98, p = 0.068) on a sample too small to detect it. Even at the clinical end of this category, the measurable win went to the person doing the caring.
Annualized, the money is small either way. The cat is $159.99 once, about $53 a year across three years plus batteries; Moflin is $429 once, about $143 a year, warranty covering only the first. The five-year view for pets that carry fees is in the subscription checklist.
Before you spend anything
Ask first. Memory-care units, adult day programs and county aging offices often already own a PARO or keep a box of Joy for All pets for loan, and several state aging agencies distribute the cheap ones free to isolated older adults, which is covered in the eldercare buyer's guide. The federal Eldercare Locator, run by the Administration for Community Living with USAging, will route you to your Area Agency on Aging by phone or text at 1-800-677-1116 or at eldercare.acl.gov. One call tells you whether the $159.99 is a purchase or a loan, and what your county already keeps on a shelf.
One email when something actually changes: a delivery verified, a price cut, a robot discontinued. No weekly filler, unsubscribe whenever.